Sun Pharma Advanced Research Company Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sales

238.78

137.25

252.96

76.82

182.87

Operating profit

-214.06

-186.75

-134.98

-310.01

-151.29

Interest

7.63

13.33

10.65

2.67

0.09

Gross profit

-210.81

-193.24

-140.22

-302.92

-137.87

EPS (Rs)

-6.86

-7.48

-5.77

-11.92

-5.55

Other income

10.88

6.84

5.41

9.76

13.51

Stock adjustment

-

-

-

-

-

Raw material

22.11

18.27

18.18

23.92

12.53

Power and fuel

-

-

-

-

-

Employee expenses

106.99

96.78

91.58

93.09

81.06

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

323.74

208.95

278.18

269.82

240.57

Provisions made

-

-

-

-

-

Depreciation

11.77

10.16

10.92

9.48

7.56

Taxation

-

-

-

-

-

Net profit / loss

-222.58

-203.40

-151.14

-312.40

-145.43

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

32.45

27.19

26.21

26.21

26.21

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

-89.65

-136.07

-53.36

-403.55

-82.73

GPM (%)

-84.44

-134.11

-54.27

-349.87

-70.21

NPM (%)

-89.15

-141.16

-58.50

-360.82

-74.06